Insider Transactions in Q1 2021 at Renaissancere Holdings LTD (RNR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,552
+14.34%
|
-
|
|
Mar 01
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,748
-4.88%
|
$1,961,916
$167.29 P/Share
|
|
Mar 01
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,660
-0.46%
|
$916,920
$162.61 P/Share
|
|
Mar 01
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,122
+8.32%
|
-
|
|
Mar 01
2021
|
Anthony M Santomero Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+4.67%
|
-
|
|
Mar 01
2021
|
Henry Klehm Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+4.51%
|
-
|
|
Mar 01
2021
|
David C Bushnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+4.67%
|
-
|
|
Mar 01
2021
|
Cynthia Trudell Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+26.09%
|
-
|
|
Mar 01
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-1.19%
|
$453,276
$162.61 P/Share
|
|
Mar 01
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,506
+10.64%
|
-
|
|
Mar 01
2021
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,257
-1.03%
|
$365,634
$162.61 P/Share
|
|
Mar 01
2021
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,179
+11.11%
|
-
|
|
Mar 01
2021
|
James L Gibbons Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+6.95%
|
-
|
|
Mar 01
2021
|
Brian Gerald John Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+5.95%
|
-
|
|
Mar 01
2021
|
Shannon Lowry Bender EVP, General Counsel & Secty |
BUY
Grant, award, or other acquisition
|
Direct |
1,967
+50.0%
|
-
|
|
Mar 01
2021
|
Valerie Rahmani Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+16.39%
|
-
|
|
Mar 01
2021
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,007
+5.48%
|
-
|
|
Mar 01
2021
|
Carol P Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+13.55%
|
-
|
|
Mar 01
2021
|
Duncan P Hennes Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+16.39%
|
-
|
|
Mar 01
2021
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,058
+21.08%
|
-
|
|
Mar 01
2021
|
Jean D Hamilton Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+3.59%
|
-
|
|
Feb 05
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-0.99%
|
$73,458
$159.35 P/Share
|
|
Feb 05
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,292
-4.69%
|
$364,428
$159.35 P/Share
|
|
Feb 05
2021
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-0.89%
|
$60,897
$159.35 P/Share
|
|
Feb 05
2021
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,412
-5.33%
|
$383,508
$159.35 P/Share
|
|
Feb 05
2021
|
Ross Curtis EVP,Chief Portfolio Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,586
-2.31%
|
$411,174
$159.35 P/Share
|
|
Feb 05
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,609
-0.64%
|
$414,831
$159.35 P/Share
|
|
Feb 05
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,287
-3.42%
|
$1,158,633
$159.35 P/Share
|